US 10273291
Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing
granted A61KA61K39/42A61P
Quick answer
US patent 10273291 (Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH
- Grant date
- Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K39/42, A61P, A61P31/18